AlphaYouGZ
Insider selling
Greg Zante sold $710K of Viking Therapeutics, Inc. (VKTX) stock
Greg Zante, Chief Financial Officer of Viking Therapeutics, Inc. (VKTX), sold 21,217 shares of VKTX stock worth $710K, per an SEC Form 4 filed Jul 30, 2026.
It was an open-market sale.
The trade happened on Jul 28, 2026, 2 days before it was made public.
VKTX has moved -11.1% since the trade date, from $33.86 to $30.11 (Sep 21, 2026 close).
- Traded
- Jul 28, 2026
- Disclosed
- Jul 30, 2026
- Filing delay
- 2 days
- Price since
- -11.1%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More VKTX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.